BCL2L1 and chronic myelogenous leukemia, BCR-ABL1 positive: Tyrosine kinase activity of Bcr-Abl in CML is associated with apoptosis inhibition by increasing the expression of the anti-apoptotic proteins Bcl-2 and Bcl-XL [38, 39], which play critical roles in the mitochondrial apoptosis pathway [40].